Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan
Clinical trial NCT01132625 · COMPLETED
Trial details
- NCT number
- NCT01132625
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2012-05-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.